Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) CRO John Anthony Dibella II sold 1,000 shares of the company’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $18.36, for a total value of $18,360.00. Following the completion of the sale, the executive directly owned 86,140 shares in the company, valued at $1,581,530.40. This trade represents a 1.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John Anthony Dibella II also recently made the following trade(s):
- On Wednesday, April 15th, John Anthony Dibella II sold 1,000 shares of Simulations Plus stock. The stock was sold at an average price of $13.37, for a total value of $13,370.00.
Simulations Plus Trading Down 0.1%
Shares of NASDAQ SLP traded down $0.01 during trading on Wednesday, reaching $18.27. The company had a trading volume of 393,694 shares, compared to its average volume of 389,041. Simulations Plus, Inc. has a twelve month low of $11.09 and a twelve month high of $21.01. The stock has a 50-day moving average price of $16.32 and a two-hundred day moving average price of $15.48. The stock has a market capitalization of $369.05 million, a PE ratio of -5.84 and a beta of 1.30.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on SLP shares. William Blair lowered Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Wall Street Zen downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. TD Cowen dropped their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 10th. Weiss Ratings raised shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 5th. Finally, Craig Hallum downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective on the stock. in a research note on Thursday, June 18th. One investment analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.88.
Check Out Our Latest Research Report on SLP
Hedge Funds Weigh In On Simulations Plus
Several hedge funds and other institutional investors have recently modified their holdings of the company. First Light Asset Management LLC grew its stake in shares of Simulations Plus by 33.7% in the first quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock worth $31,120,000 after purchasing an additional 663,906 shares in the last quarter. Ameriprise Financial Inc. raised its stake in shares of Simulations Plus by 25.3% during the second quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock valued at $15,277,000 after purchasing an additional 176,747 shares in the last quarter. Marshall Wace LLP lifted its holdings in Simulations Plus by 127.5% in the fourth quarter. Marshall Wace LLP now owns 569,783 shares of the technology company’s stock worth $10,387,000 after purchasing an additional 319,301 shares during the period. Stephens Investment Management Group LLC lifted its holdings in Simulations Plus by 30.8% in the fourth quarter. Stephens Investment Management Group LLC now owns 513,728 shares of the technology company’s stock worth $9,365,000 after purchasing an additional 120,888 shares during the period. Finally, First Eagle Investment Management LLC grew its position in Simulations Plus by 1,898.1% in the 4th quarter. First Eagle Investment Management LLC now owns 457,155 shares of the technology company’s stock valued at $8,334,000 after buying an additional 434,275 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Articles
- Five stocks we like better than Simulations Plus
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
